UK court bolsters authority of CE mark
This article was originally published in Clinica
A legal ruling in the UK has seriously undermined the power of national governments to challenge decisions made in other European countries that products are safe for marketing.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.